Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China
· Delayed Price · Currency is CNY 3.430
+0.070 (2.08%)
Apr 29, 2026, 3:04 PM CST
SHE:300026 Revenue
In the year 2025, Tianjin Chase Sun Pharmaceutical Co.,Ltd had annual revenue of 4.94B CNY, down -14.55%. Tianjin Chase Sun Pharmaceutical Co.,Ltd had revenue of 792.56M in the quarter ending December 31, 2025, a decrease of -40.93%.
Revenue
4.94B
Revenue Growth
-14.55%
P/S Ratio
2.20
Revenue / Employee
883.25K
Employees
5,297
Market Cap
10.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.94B | -841.64M | -14.55% |
| Dec 31, 2024 | 5.78B | -326.09M | -5.34% |
| Dec 31, 2023 | 6.11B | -541.17M | -8.14% |
| Jan 1, 2023 | 6.65B | -1.02B | -13.30% |
| Dec 31, 2021 | 7.67B | 1.18B | 18.22% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hubei Hongyuan Pharmaceutical Technology | 1.77B |
| Beijing Foyou Pharma CO.,LTD | 3.49B |
| Harbin Pharmaceutical Group | 15.96B |
| Yantai Dongcheng Pharmaceutical Group | 2.68B |
| Shanghai Yizhong Pharmaceutical | 317.08M |
| Mayinglong Pharmaceutical Group | 3.91B |
| Zhejiang CONBA Pharmaceutical | 6.69B |
| PharmaBlock Sciences (Nanjing) | 2.03B |